Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    February 2017
  1. BANERJEE S, Shi H, Banasik M, Moon H, et al
    Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Virology. 2017;505:113-126.
    PubMed     Text format     Abstract available


  2. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    PubMed     Text format     Abstract available


    January 2017
  3. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    PubMed     Text format     Abstract available


  4. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    PubMed     Text format     Abstract available


  5. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    PubMed     Text format     Abstract available


  6. GALLAGHER JR, Torian U, McCraw DM, Harris AK, et al
    Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.
    Virology. 2017;502:176-187.
    PubMed     Text format     Abstract available


    December 2016
  7. FERNANDEZ-SAINZ I, Medina GN, Ramirez-Medina E, Koster MJ, et al
    Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Virology. 2016;502:123-132.
    PubMed     Text format     Abstract available


    November 2016
  8. CHENG BY, Nogales A, de la Torre JC, Martinez-Sobrido L, et al
    Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
    Virology. 2016;501:35-46.
    PubMed     Text format     Abstract available


  9. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology. 2016;500:209-217.
    PubMed     Text format     Abstract available


    October 2016
  10. YAMSHCHIKOV V, Manuvakhova M, Rodriguez E, Hebert C, et al
    Development of a human live attenuated West Nile infectious DNA vaccine: Identification of a minimal mutation set conferring the attenuation level acceptable for a human vaccine.
    Virology. 2016;500:122-129.
    PubMed     Text format     Abstract available


  11. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
    Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Virology. 2016;500:1-10.
    PubMed     Text format     Abstract available


  12. LULF AT, Freudenstein A, Marr L, Sutter G, et al
    Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes.
    Virology. 2016;499:322-330.
    PubMed     Text format     Abstract available


  13. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
    A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Virology. 2016;499:288-297.
    PubMed     Text format     Abstract available


    September 2016
  14. RAUFF D, Strydom C, Abolnik C
    Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
    Virology. 2016;498:226-239.
    PubMed     Text format     Abstract available


    August 2016
  15. PARK SJ, Si YJ, Kim J, Song MS, et al
    Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus.
    Virology. 2016;498:36-43.
    PubMed     Text format     Abstract available


    July 2016
  16. ARNDT WD, White SD, Johnson BP, Huynh T, et al
    Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.
    Virology. 2016;497:125-135.
    PubMed     Text format     Abstract available


  17. JEON JS, Won YH, Kim IK, Ahn JH, et al
    Analysis of single nucleotide polymorphism among Varicella-Zoster Virus and identification of vaccine-specific sites.
    Virology. 2016;496:277-286.
    PubMed     Text format     Abstract available


    May 2016
  18. GIRIA M, Santos L, Louro J, Rebelo de Andrade H, et al
    Reverse genetics vaccine seeds for influenza: Proof of concept in the source of PB1 as a determinant factor in virus growth and antigen yield.
    Virology. 2016;496:21-27.
    PubMed     Text format     Abstract available


  19. RAI DK, Segundo FD, Schafer E, Burrage TG, et al
    Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity.
    Virology. 2016;495:136-147.
    PubMed     Text format     Abstract available


  20. SUN X, Guo N, Li D, Jin M, et al
    Binding specificity of P[8] VP8* proteins of rotavirus vaccine strains with histo-blood group antigens.
    Virology. 2016;495:129-135.
    PubMed     Text format     Abstract available


  21. ALSALEH K, Khou C, Frenkiel MP, Lecollinet S, et al
    The E glycoprotein plays an essential role in the high pathogenicity of European-Mediterranean IS98 strain of West Nile virus.
    Virology. 2016;492:53-65.
    PubMed     Text format     Abstract available


    April 2016
  22. HWANG HS, Lee YT, Kim KH, Park S, et al
    Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Virology. 2016;494:215-224.
    PubMed     Text format     Abstract available


    March 2016
  23. LIU F, Sun X, Fairman J, Lewis DB, et al
    A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.
    Virology. 2016;492:197-203.
    PubMed     Text format     Abstract available


    February 2016
  24. OKAMOTO K, Ami Y, Suzaki Y, Otsuki N, et al
    Analysis of the temperature sensitivity of Japanese rubella vaccine strain TO-336.vac and its effect on immunogenicity in the guinea pig.
    Virology. 2016;491:89-95.
    PubMed     Text format     Abstract available


  25. RAJAO DS, Sandbulte MR, Gauger PC, Kitikoon P, et al
    Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.
    Virology. 2016;491:79-88.
    PubMed     Text format     Abstract available


  26. YE C, Guo JC, Gao JC, Wang TY, et al
    Genomic analyses reveal that partial sequence of an earlier pseudorabies virus in China is originated from a Bartha-vaccine-like strain.
    Virology. 2016;491:56-63.
    PubMed     Text format     Abstract available


  27. LEE YJ, Jang YH, Kim P, Lee YH, et al
    Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin.
    Virology. 2016;491:1-9.
    PubMed     Text format     Abstract available


  28. HIDAJAT R, Nickols B, Forrester N, Tretyakova I, et al
    Next generation sequencing of DNA-launched Chikungunya vaccine virus.
    Virology. 2016;490:83-90.
    PubMed     Text format     Abstract available


  29. FABURAY B, Gaudreault NN, Liu Q, Davis AS, et al
    Development of a sheep challenge model for Rift Valley fever.
    Virology. 2016;489:128-40.
    PubMed     Text format     Abstract available


    January 2016
  30. DIAZ FM, Knipe DM
    Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.
    Virology. 2016;488:61-7.
    PubMed     Text format     Abstract available


  31. HARRISON ML, Desaulniers MA, Noyce RS, Evans DH, et al
    The acidic C-terminus of vaccinia virus I3 single-strand binding protein promotes proper assembly of DNA-protein complexes.
    Virology. 2016;489:212-222.
    PubMed     Text format     Abstract available


  32. ZHANG Y, Zhang S, Li W, Hu Y, et al
    A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies.
    Virology. 2016;489:165-172.
    PubMed     Text format     Abstract available


  33. VZOROV AN, Wang L, Chen J, Wang BZ, et al
    Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.
    Virology. 2016;489:141-150.
    PubMed     Text format     Abstract available


  34. EREN E, Zamuda K, Patton JT
    Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species.
    Virology. 2016;487:150-62.
    PubMed     Text format     Abstract available


    December 2015
  35. GABRIEL B, Fiebig U, Hohn O, Plesker R, et al
    Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Virology. 2015;489:1-11.
    PubMed     Text format     Abstract available


  36. LEE DH, Fusaro A, Song CS, Suarez DL, et al
    Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea.
    Virology. 2015;488:225-231.
    PubMed     Text format     Abstract available


    November 2015
  37. YAMSHCHIKOV V, Manuvakhova M, Rodriguez E
    Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design.
    Virology. 2015;487:198-206.
    PubMed     Text format     Abstract available


  38. GAO L, Wang L, Huang C, Yang L, et al
    HP-PRRSV is attenuated by de-optimization of codon pair bias in its RNA-dependent RNA polymerase nsp9 gene.
    Virology. 2015;485:135-44.
    PubMed     Text format     Abstract available


  39. LEE YT, Kim KH, Hwang HS, Lee Y, et al
    Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
    Virology. 2015;485:36-46.
    PubMed     Text format     Abstract available


    October 2015
  40. SCHELLENBACHER C, Shafti-Keramat S, Huber B, Fink D, et al
    Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.
    Virology. 2015;486:284-290.
    PubMed     Text format     Abstract available


  41. GU L, Krendelchtchikova V, Krendelchtchikov A, Farrow AL, et al
    Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy.
    Virology. 2015;487:75-84.
    PubMed     Text format     Abstract available


  42. HABTE HH, Banerjee S, Shi H, Qin Y, et al
    Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.
    Virology. 2015;486:187-197.
    PubMed     Text format     Abstract available


  43. KIM SH, Chen S, Jiang X, Green KY, et al
    Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.
    Virology. 2015;484:163-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: